Bioray Biotech Co (ROCO:7561) FCF Margin % : 5.19% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Bioray Biotech Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bioray Biotech Co's Free Cash Flow for the six months ended in Dec. 2023 was NT$5.1 Mil. Bioray Biotech Co's Revenue for the six months ended in Dec. 2023 was NT$97.8 Mil. Therefore, Bioray Biotech Co's FCF Margin % for the quarter that ended in Dec. 2023 was 5.19%.

As of today, Bioray Biotech Co's current FCF Yield % is -1.40%.

The historical rank and industry rank for Bioray Biotech Co's FCF Margin % or its related term are showing as below:

ROCO:7561' s FCF Margin % Range Over the Past 10 Years
Min: -31.8 Med: -17.42 Max: -0.74
Current: -5.71

During the past 7 years, the highest FCF Margin % of Bioray Biotech Co was -0.74%. The lowest was -31.80%. And the median was -17.42%.

ROCO:7561's FCF Margin % is ranked worse than
63.83% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 0.25 vs ROCO:7561: -5.71

Bioray Biotech Co FCF Margin % Historical Data

The historical data trend for Bioray Biotech Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioray Biotech Co FCF Margin % Chart

Bioray Biotech Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-0.74

-31.80

-4.53

-30.38

-5.71

Bioray Biotech Co Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial							17.56	-70.42	4.60	-17.03	5.19

Competitive Comparison of Bioray Biotech Co's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Bioray Biotech Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioray Biotech Co's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bioray Biotech Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bioray Biotech Co's FCF Margin % falls into.

Bioray Biotech Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bioray Biotech Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-10.945	/	191.83
	=	-5.71 %

Bioray Biotech Co's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	5.073	/	97.772
	=	5.19 %

Bioray Biotech Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Bioray Biotech Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioray Biotech Co (ROCO:7561) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioray Biotech Co Ltd (ROCO:7561) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 21-3, Shennong East Road, Changzhi Township, Pingtung County, Pingtung City, TWN, 90846

Website

http://www.bio-ray.com.tw

Bioray Biotech Co Ltd is engaged in the development and manufacturing of biological agents, including functional probiotics, medicinal fungi, and immune cell preparations. The company provides capsules, powders, lozenges, and liquids for Skincare, Anti-aging and anti-inflammatory, Silver Hair Maintenance, and Microbe and mineral supplement among others.

Bioray Biotech Co (ROCO:7561) Headlines

No Headlines